These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 483361)

  • 21. Modulation of lymphocyte proliferative responses to mitogens and antigens by complement components C1, C4 and C2.
    Laham MN; Caldwell JR; Panush RS
    J Clin Lab Immunol; 1982 Oct; 9(1):39-47. PubMed ID: 6983586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new complement-mediated cytolytic mechanism--the C1-bypass activation pathway.
    May JE; Frank MM
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):649-52. PubMed ID: 4123687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simplified method for the preparation of EAC14.
    Matre R; Tönder O; Wesenberg F
    J Immunol Methods; 1980; 39(1-2):25-9. PubMed ID: 7007511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a hemolytic assay for mouse complement components in sera and the variation of their levels with age.
    Fukuoka Y; Seino J; Okuda T; Tachibana T
    Tohoku J Exp Med; 1982 May; 137(1):79-90. PubMed ID: 6808704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cause and methods of elimination of nonspecific immunofluorescence of Treponema pallidum. Role of human complement in the Treponema pallidum immunofluorescence reaction].
    Ruczkowska J
    Przegl Dermatol; 1981; 68(2):181-7. PubMed ID: 7029658
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of antiserum and complement in the acute antibody-mediated rejection of mouse skin allografts in strain combinations with increasing histoincompatibility.
    Berden JH; Gerlag PG; Hagemann JF; Koene RA
    Transplantation; 1977 Sep; 24(3):175-82. PubMed ID: 339430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interruption of the sequential release of small and large molecules from tumor cells by low temperature during cytolysis mediated by immune T-cells or complement.
    Martz E; Burakoff SJ; Benacerraf B
    Proc Natl Acad Sci U S A; 1974 Jan; 71(1):177-81. PubMed ID: 4359327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysis of horse red blood cells mediated by antibody-independent activation of the alternative pathway of chicken complement.
    Ohta H; Yoshikawa Y; Kai C; Yamanouchi K; Okada H
    Immunology; 1984 Jul; 52(3):437-44. PubMed ID: 6430791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of high complement levels in Mus hortulanus and BUB mice.
    Ong GL; Baker AE; Mattes MJ
    J Immunol Methods; 1992 Sep; 154(1):37-45. PubMed ID: 1401942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical characterization of the anomalous reaction of anti-H-2b alloantiserum with a chemically induced sarcoma of H-2k origin.
    Rogers MJ; Carbone G; Ballinari D; Cattaneo M; Parmiani G
    Transplant Proc; 1981 Dec; 13(4):1774-81. PubMed ID: 7330966
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of complement factors in acute antibody-mediated rejection of mouse skin allografts.
    Berden JH; Capel PJ; Koene RA
    Eur J Immunol; 1978 Mar; 8(3):158-62. PubMed ID: 350593
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanism of enhanced complement-dependent cytotoxicity of papain-treated lymphocytes: evidence for increased stability of classical pathway C3 convertase.
    Lublin DM; Grumet FC
    J Immunol; 1982 Feb; 128(2):866-70. PubMed ID: 6915075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.
    Berman S; Gewurz H; Mold C
    J Immunol; 1986 Feb; 136(4):1354-9. PubMed ID: 3944459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in susceptibility of a human lymphoid cell line to immune lysis during the cell cycle. Lack of correlation with antigen density and complement binding.
    Pellegrino MA; Ferrone S; Cooper NR; Dierich MP; Reisfeld RA
    J Exp Med; 1974 Aug; 140(2):578-90. PubMed ID: 4527075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutathione inhibits antibody and complement-mediated immunologic cell injury via multiple mechanisms.
    Zhang Z; Zhang X; Fang X; Niimi M; Huang Y; Piao H; Gao S; Fan J; Yao J
    Redox Biol; 2017 Aug; 12():571-581. PubMed ID: 28390315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential susceptibility of haemolysin-sensitized erythrocytes to complement-mediated cytotoxicity: a biological manifestation of the relationship between antibody availability and complement fixation.
    Bakács T; Ringwald G; Kimber I
    J Clin Lab Immunol; 1989 Oct; 30(2):61-7. PubMed ID: 2641530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of naturally occurring H-2-specific antibodies in mouse sera monitored by "superreactive" rabbit complement.
    Cerný-Provaznik R; Iványi P
    Tissue Antigens; 1985 Oct; 26(4):259-61. PubMed ID: 4071527
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of C4-binding protein in the defective lysis of sensitized sheep erythrocytes by mouse complement.
    van Amerongen A; van Dijk H; Willers JM
    Int Arch Allergy Appl Immunol; 1982; 68(3):209-13. PubMed ID: 7085115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.